3/9
04:05 pm
bhvn
Biohaven (BHVN) had its "strong-buy" rating reaffirmed by Raymond James Financial, Inc..
Low
Report
Biohaven (BHVN) had its "strong-buy" rating reaffirmed by Raymond James Financial, Inc..
3/3
05:03 pm
bhvn
Biohaven (BHVN) had its "outperform" rating reaffirmed by Leerink Partners.
Low
Report
Biohaven (BHVN) had its "outperform" rating reaffirmed by Leerink Partners.
3/3
10:35 am
bhvn
Rating for BHVN
Low
Report
Rating for BHVN
3/3
10:35 am
bhvn
Rating for BHVN
Low
Report
Rating for BHVN
2/5
04:18 pm
bhvn
Biohaven initiated with a Buy at Goldman Sachs
Medium
Report
Biohaven initiated with a Buy at Goldman Sachs
2/5
04:18 pm
bhvn
Biohaven initiated with a Buy at Goldman Sachs
Medium
Report
Biohaven initiated with a Buy at Goldman Sachs
2/5
04:18 pm
bhvn
Biohaven initiated with a Buy at Goldman Sachs
Medium
Report
Biohaven initiated with a Buy at Goldman Sachs
1/21
05:50 am
bhvn
Rating for BHVN
Medium
Report
Rating for BHVN
1/21
05:50 am
bhvn
Rating for BHVN
Medium
Report
Rating for BHVN
1/21
05:09 am
bhvn
Biohaven upgraded to Outperform from Sector Perform at RBC Capital
Low
Report
Biohaven upgraded to Outperform from Sector Perform at RBC Capital
1/21
05:09 am
bhvn
Biohaven upgraded to Outperform from Sector Perform at RBC Capital
Low
Report
Biohaven upgraded to Outperform from Sector Perform at RBC Capital
1/6
10:24 am
bhvn
Rating for BHVN
Low
Report
Rating for BHVN
1/6
10:24 am
bhvn
Rating for BHVN
Low
Report
Rating for BHVN
12/26
07:17 am
bhvn
Biohaven (NYSE:BHVN) had its "market perform" rating reaffirmed by analysts at William Blair.
High
Report
Biohaven (NYSE:BHVN) had its "market perform" rating reaffirmed by analysts at William Blair.
12/26
07:17 am
bhvn
Biohaven (NYSE:BHVN) had its "market perform" rating reaffirmed by analysts at William Blair.
High
Report
Biohaven (NYSE:BHVN) had its "market perform" rating reaffirmed by analysts at William Blair.
12/26
07:17 am
bhvn
Biohaven (NYSE:BHVN) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
High
Report
Biohaven (NYSE:BHVN) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
12/26
07:17 am
bhvn
Biohaven (NYSE:BHVN) had its "neutral" rating reaffirmed by analysts at HC Wainwright.
High
Report
Biohaven (NYSE:BHVN) had its "neutral" rating reaffirmed by analysts at HC Wainwright.